loader2
Partner With Us NRI

Bajaj Healthcare Ltd

Company details

384.00
396.50
256.80
457.55
6M Return -1.26%
1Y Return -9.85%
Mkt Cap.(Cr) 1,059.76
Volume 2,627
Div Yield 0.38%
OI
-
OI Chg %
-
Volume 2,627

Open Free Demat Account Online with ICICIDIRECT

Bajaj Healthcare Ltd.

Q1FY23 Quarterly Result Announced for Bajaj Healthcare Ltd.

Pharmaceuticals firm Bajaj Healthcare announced Q1FY23 Result :

  • Revenue from Operations has marginally degrown by 7.32% from Rs.1,856.89 Mn in Q1 FY22 to Rs.1720.69 Mn in Q1 FY23 mainly due to contraction of Covid-19 led opportunities.
  • EBITDA has degrown by 22.85% from Rs.334.98 Mn in Q1 FY22 to Rs.258.44 Mn in Q1 FY23. There was de-growth in EBIDTA Margins from 18.04% in Q1 FY22 to 15.02% in Q1 FY23 on a YoY basis. The degrowth in EBITDA margins was mainly on account of weakening of Indian Rupee, thereby leading to an increase in imported raw material cost. The EBITDA margins strengthened on a sequential quarter basis by 67bps.
  • Net profit has decline by 37.46% from Rs.192.18 Mn in Q1 FY22 to Rs. 120.19 Mn in Q1 FY23. The Net Profit Margins were at 6.98% in Q1 FY23 from 10.35% in Q1 FY22 owing to a decline in EBITDA margins as explained above.

Commenting on the Q1 FY23 results, Mr. Sajankumar Bajaj (Chairman) said: “We are pleased to inform all our stakeholders that the company has reported an overall stable financial performance in Q1 FY23 despite witnessing inflationary headwinds for the major part of the quarter. Despite declining contribution from Covid related products, The company was able to retain its revenue achieved in Q1FY22 on account of covid related demand and post an improvement in quarterly EBITDA margins on a sequential basis."

Result PDF

View Other Company Results

FINANCIALS

Sales

Operating Profit

Profit after Tax

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after Tax

PE

Debt/Equity

P BV

COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 328.49 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,728.09 -29,609.20
LAST 3M 42,048.80 -31,382.80
LAST 6M 65,127.04 16,114.05
LAST 12M 194,271.06 -118,498.61

INFORMATION

Stock PE (TTM)

17.09

Promoter Holding

67.42%

Book Value

129.3057

ROCE

19.9%

ROE

24.33%

Description

  • Bajaj Healthcare Ltd. is in the business of manufacturing pharmaceutical products and bulk drugs. It is valued at Rs. 917 crore on the stock exchange. The company was incorporated in 1993. The key figures in the company’s management are Mr Pakshal A Jain, Mr Rupesh H Nikam, and Mr Sajan Kumar R Bajaj. Bajaj Healthcare’s net profit was Rs. 17.45 crore in the third quarter of FY 2021-22. The share price of Bajaj Healthcare is traded under the script name of BAJAJHCARE on both the stock exchanges (NSE & BSE). 

    Bajaj Healthcare’s product segment comprises formulations and bulk drugs. Its therapeutic API portfolio includes anticonvulsants, vitamins, bactericidal, bronchodilators, and so on. It offers anti-Platelets, anti-arrhythmia, anti-hypertensive, and a few more in the FDF segment.

    Bajaj Healthcare Ltd.’s price-to-earnings (PE) ratio and price-to-book (PB) ratio are better than its industry average. The PE ratio is 10.89, and the PB ratio is 3.52. For the past five years, the company’s average annual revenue and profit growth rates were 24.36% and 58.88%, respectively. Bajaj Healthcare reported a net income of Rs. 7.80 crore, Rs. 15.20 crore, Rs. 16.30 crore, Rs. 25.25 crore, and Rs. 83.11 crore in the past five financial years. The company declared a dividend of Rs. 1.38 and an EPS of Rs. 30.11. The company’s overall assets have increased significantly over the past two years. However, total liabilities have also increased during the same period. During the past five years, the company’s average debt-to-income ratio and current ratio have been 67.1% and 117.13%, respectively. For the financial year 2021, the company’s financials showed a negative free cash flow.

    On April 6, 2022, Bajaj Healthcare’s share price on BSE closed at Rs. 373.75. Bajaj Healthcare’s share price performance on the price chart was quite satisfying, as it reported an annual return of 64.39% in the past 12 months. The 52-week low of Bajaj Healthcare’s share price was Rs. 213.45. The high for the same period was recorded at Rs. 511.90. Investing in Bajaj Healthcare is extremely risky due to its high volatility of 3.43x the NIFTY. Some of the industries’ key competitors of Bajaj Healthcare on the stock exchange are Cipla Ltd., Gland Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Dr Reddy’s Laboratories Ltd., and Torrent Pharmaceuticals Ltd. 

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

602-606 Bhoomi Velocity Infote, Road No 23 Wagle Indl Estate, Thane, Maharashtra, 400604

Tel : 91-22-66177400/401
Email : investors:bajajhealth.com
Website : http://www.bajajhealth.com

Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Oct
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 539872
NSE Code : BAJAJHCARE
Book Closure Date (Month) : Oct
BSE Group : B
ISIN : INE411U01027

ICICIdirect Bajaj Healthcare Ltd FAQ

You can buy Bajaj Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bajaj Healthcare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 08, 2023 04:01 PM the closing price of Bajaj Healthcare Ltd was ₹ 384.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 08, 2023 04:01 PM, the market cap of Bajaj Healthcare Ltd stood at ₹ 1,059.76.
The latest PE ratio of Bajaj Healthcare Ltd as of Feb 08, 2023 04:01 PM is 17.09
The latest PB ratio of Bajaj Healthcare Ltd as of Feb 08, 2023 04:01 PM is 0.33
The 52-week high of Bajaj Healthcare Ltd is ₹ 457.55 while the 52-week low is ₹ 256.80

Download Our App

market app
market app